Clinical efficacy of herbal extracts in treatment of mild to moderate acne vulgaris : an 8-week, double-blinded, randomized, controlled trial

BACKGROUND: Herbal extracts with fewer adverse effects can be an alternative to these drugs because they can target various molecular pathways of acne pathogenesis.

OBJECTIVES: To evaluate the clinical efficacy of herbal extracts (mangosteen, Lithospermum officinale, Tribulus terrestris L., Houttuynia cordata Thunb) for the treatment of mild to moderate acne vulgaris.

METHODS: Sixty patients were randomized in a 1:1 ratio to receive blinded treatment with herbal extracts or vehicle for 8 weeks. Inflammatory and non-inflammatory acne lesion counts, Investigator's Global Assessment, patient's satisfaction and safety profiles were assessed. We also performed skin biopsy at baseline and week 8 to confirm immunological changes with immunohistochemistry staining.

RESULTS: By the end of the study period, both inflammatory and non-inflammatory acne lesion counts were significantly decreased in herbal extracts group (p< .05). In immunohistochemistry staining, expressions of IL-1α, IL-8, and keratin 16 were significantly decreased in herbal extracts group compared to vehicle group from baseline to week 8. There was no serious adverse events in both groups.

CONCLUSIONS: This herbal extracts can be a new therapeutic option for patients with mild to moderate acne vulgaris who are reluctant to use drugs.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:32

Enthalten in:

The Journal of dermatological treatment - 32(2021), 3 vom: 21. Mai, Seite 297-301

Sprache:

Englisch

Beteiligte Personen:

Yang, Ji Hoon [VerfasserIn]
Hwang, Eun Ju [VerfasserIn]
Moon, Jungyoon [VerfasserIn]
Yoon, Ji Young [VerfasserIn]
Kim, Ji Won [VerfasserIn]
Choi, Sungjun [VerfasserIn]
Cho, Soo Ick [VerfasserIn]
Suh, Dae Hun [VerfasserIn]

Links:

Volltext

Themen:

Acne
Herbal extracts
Inflammation
Interleukin-1alpha
Journal Article
Plant Extracts
Randomized Controlled Trial

Anmerkungen:

Date Completed 21.06.2021

Date Revised 22.04.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/09546634.2019.1657792

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM300349912